Biosenic SA
F:BT1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Biosenic SA.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Biosenic Does
BioSenic SA is a biotech company, which engages in the development of clinical assets. The firm develops cell therapy products for the treatment and regeneration of bone tissue and bone reconstruction applications, osteonecrosis, ununited fractures, and maxillo-facial reconstruction. The company is engaged in research, enable adult stem cell isolation, expansion, and osteogenic differentiation. The Company’s therapeutic area focus is bone diseases, with extensions to joint, mainly osteoarthritis and disc degeneration.
- Headquarters
- Belgium BE
- Employees
- 3
- IPO date
- Feb 6, 2015
Balance Sheet
Continue BT1 Research
Decided on Biosenic? Get an email when BT1 reaches the price you’d buy at. Free with an account.